KBC Group NV Has $48.25 Million Position in Xylem Inc. $XYL

KBC Group NV trimmed its stake in Xylem Inc. (NYSE:XYL) by 21.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 373,006 shares of the industrial products company’s stock after selling 103,728 shares during the quarter. KBC Group NV owned about 0.15% of Xylem worth $48,252,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP grew its stake in shares of Xylem by 61.1% in the 1st quarter. Allworth Financial LP now owns 2,068 shares of the industrial products company’s stock valued at $239,000 after buying an additional 784 shares during the period. Alps Advisors Inc. boosted its holdings in Xylem by 7.8% in the first quarter. Alps Advisors Inc. now owns 2,916 shares of the industrial products company’s stock worth $348,000 after acquiring an additional 210 shares in the last quarter. CWM LLC grew its stake in Xylem by 8.3% in the first quarter. CWM LLC now owns 8,635 shares of the industrial products company’s stock valued at $1,031,000 after acquiring an additional 660 shares during the period. Signaturefd LLC increased its holdings in shares of Xylem by 16.4% during the first quarter. Signaturefd LLC now owns 5,901 shares of the industrial products company’s stock valued at $705,000 after acquiring an additional 832 shares in the last quarter. Finally, Wealthfront Advisers LLC increased its holdings in shares of Xylem by 3.8% during the first quarter. Wealthfront Advisers LLC now owns 25,540 shares of the industrial products company’s stock valued at $3,051,000 after acquiring an additional 924 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of XYL opened at $149.68 on Thursday. The stock has a 50 day moving average of $146.02 and a 200 day moving average of $136.52. The company has a market capitalization of $36.44 billion, a price-to-earnings ratio of 38.48, a PEG ratio of 2.50 and a beta of 1.15. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The company has a current ratio of 1.96, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. During the same quarter in the prior year, the company earned $1.11 EPS. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Victoria D. Harker sold 1,700 shares of the firm’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director owned 16,875 shares in the company, valued at approximately $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 13,121 shares of company stock worth $1,982,459. Insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Barclays lifted their price target on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Mizuho set a $160.00 price objective on shares of Xylem in a report on Wednesday, October 29th. Citigroup boosted their target price on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Cowen reaffirmed a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $166.90.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.